Literature DB >> 29388143

Preparation of Small RNA NGS Libraries from Biofluids.

Alton Etheridge1, Kai Wang2, David Baxter2, David Galas3.   

Abstract

Next generation sequencing (NGS) is a powerful method for transcriptome analysis. Unlike other gene expression profiling methods, such as microarrays, NGS provides additional information such as splicing variants, sequence polymorphisms, and novel transcripts. For this reason, NGS is well suited for comprehensive profiling of the wide range of extracellular RNAs (exRNAs) in biofluids. ExRNAs are of great interest because of their possible biological role in cell-to-cell communication and for their potential use as biomarkers or for therapeutic purposes. Here, we describe a modified protocol for preparation of small RNA libraries for NGS analysis. This protocol has been optimized for use with low-input exRNA-containing samples, such as plasma or serum, and has modifications designed to reduce the sequence-specific bias typically encountered with commercial small RNA library construction kits.

Keywords:  Biofluid; Extracellular RNA; Plasma; Sequencing; Serum; miRNA

Mesh:

Substances:

Year:  2018        PMID: 29388143     DOI: 10.1007/978-1-4939-7652-2_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC.

Authors:  Takehito Shukuya; Vikas Ghai; Joseph M Amann; Tamio Okimoto; Konstantin Shilo; Taek-Kyun Kim; Kai Wang; David P Carbone
Journal:  J Thorac Oncol       Date:  2020-06-19       Impact factor: 15.609

2.  Extracellular Vesicle Encapsulated MicroRNAs in Patients with Type 2 Diabetes Are Affected by Metformin Treatment.

Authors:  Vikas Ghai; Taek-Kyun Kim; Alton Etheridge; Trine Nielsen; Torben Hansen; Oluf Pedersen; David Galas; Kai Wang
Journal:  J Clin Med       Date:  2019-05-07       Impact factor: 4.241

3.  Circulating RNAs as predictive markers for the progression of type 2 diabetes.

Authors:  Vikas Ghai; David Baxter; Xiaogang Wu; Taek-Kyun Kim; Johanna Kuusisto; Markku Laakso; Tom Connolly; Yong Li; Patricia Andrade-Gordon; Kai Wang
Journal:  J Cell Mol Med       Date:  2019-02-07       Impact factor: 5.310

4.  The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA.

Authors:  Ming-Jen Lee; Shannon Fallen; Yong Zhou; David Baxter; Kelsey Scherler; Meng-Fai Kuo; Kai Wang
Journal:  J Clin Med       Date:  2019-10-10       Impact factor: 4.241

Review 5.  Technological Approaches in the Analysis of Extracellular Vesicle Nucleotide Sequences.

Authors:  Tine Tesovnik; Barbara Jenko Bizjan; Robert Šket; Maruša Debeljak; Tadej Battelino; Jernej Kovač
Journal:  Front Bioeng Biotechnol       Date:  2021-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.